Sasha Blay

ORCID

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 11

Top Venues

Nature communications

Nature cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Nicholas Light, Mehdi Layeghifard, Ayush Attery, Vallijah Subasri, Matthew Zatzman, Nathaniel D Anderson, Rupal Hatkar, Sasha Blay, David Chen, Ana Novokmet, Fabio Fuligni, James Tran, Richard de Borja, Himanshi Agarwal, Larissa Waldman, Lisa M Abegglen, Daniel Albertson, Jonathan L Finlay, Jordan R Hansford, Sam Behjati, Anita Villani, Moritz Gerstung, Ludmil B Alexandrov, Gino R Somers, Joshua D Schiffman, Varda Rotter, David Malkin, Adam Shlien
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis. Nature communications 14 (1) (2023)
Nicholas Light, Mehdi Layeghifard, Ayush Attery, Vallijah Subasri, Matthew Zatzman, Nathaniel D Anderson, Rupal Hatkar, Sasha Blay, David Chen, Ana Novokmet, Fabio Fuligni, James Tran, Richard de Borja, Himanshi Agarwal, Larissa Waldman, Lisa M Abegglen, Daniel Albertson, Jonathan L Finlay, Jordan R Hansford, Sam Behjati, Anita Villani, Moritz Gerstung, Ludmil B Alexandrov, Gino R Somers, Joshua D Schiffman, Varda Rotter, David Malkin, Adam Shlien
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis. Nature communications 14 (1) (2023)
Nicholas Light, Mehdi Layeghifard, Ayush Attery, Vallijah Subasri, Matthew Zatzman, Nathaniel D Anderson, Rupal Hatkar, Sasha Blay, David Chen, Ana Novokmet, Fabio Fuligni, James Tran, Richard de Borja, Himanshi Agarwal, Larissa Waldman, Lisa M Abegglen, Daniel Albertson, Jonathan L Finlay, Jordan R Hansford, Sam Behjati, Anita Villani, Moritz Gerstung, Ludmil B Alexandrov, Gino R Somers, Joshua D Schiffman, Varda Rotter, David Malkin, Adam Shlien
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis. Nature communications 14 (1) (2023)
Nicholas Light, Mehdi Layeghifard, Ayush Attery, Vallijah Subasri, Matthew Zatzman, Nathaniel D Anderson, Rupal Hatkar, Sasha Blay, David Chen, Ana Novokmet, Fabio Fuligni, James Tran, Richard de Borja, Himanshi Agarwal, Larissa Waldman, Lisa M Abegglen, Daniel Albertson, Jonathan L Finlay, Jordan R Hansford, Sam Behjati, Anita Villani, Moritz Gerstung, Ludmil B Alexandrov, Gino R Somers, Joshua D Schiffman, Varda Rotter, David Malkin, Adam Shlien
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis. Nature communications 14 (1) (2023)
Nicholas Light, Mehdi Layeghifard, Ayush Attery, Vallijah Subasri, Matthew Zatzman, Nathaniel D Anderson, Rupal Hatkar, Sasha Blay, David Chen, Ana Novokmet, Fabio Fuligni, James Tran, Richard de Borja, Himanshi Agarwal, Larissa Waldman, Lisa M Abegglen, Daniel Albertson, Jonathan L Finlay, Jordan R Hansford, Sam Behjati, Anita Villani, Moritz Gerstung, Ludmil B Alexandrov, Gino R Somers, Joshua D Schiffman, Varda Rotter, David Malkin, Adam Shlien
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis. Nature communications 14 (1) (2023)
Nicholas Light, Mehdi Layeghifard, Ayush Attery, Vallijah Subasri, Matthew Zatzman, Nathaniel D Anderson, Rupal Hatkar, Sasha Blay, David Chen, Ana Novokmet, Fabio Fuligni, James Tran, Richard de Borja, Himanshi Agarwal, Larissa Waldman, Lisa M Abegglen, Daniel Albertson, Jonathan L Finlay, Jordan R Hansford, Sam Behjati, Anita Villani, Moritz Gerstung, Ludmil B Alexandrov, Gino R Somers, Joshua D Schiffman, Varda Rotter, David Malkin, Adam Shlien
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis. Nature communications 14 (1) (2023)
Anita Villani, Scott Davidson, Nisha Kanwar, Winnie W Lo, Yisu Li, Sarah Cohen-Gogo, Fabio Fuligni, Lisa-Monique Edward, Nicholas Light, Mehdi Layeghifard, Ricardo Harripaul, Larissa Waldman, Bailey Gallinger, Federico Comitani, Ledia Brunga, Reid Hayes, Nathaniel D Anderson, Arun K Ramani, Kyoko E Yuki, Sasha Blay, Brittney Johnstone, Cara Inglese, Rawan Hammad, Catherine Goudie, Andrew Shuen, Jonathan D Wasserman, Rosemarie E Venier, Marianne Eliou, Miranda Lorenti, Carol Ann Ryan, Michael Braga, Meagan Gloven-Brown, Jianan Han, Maria Montero, Famida Spatare, James A Whitlock, Stephen W Scherer, Kathy Chun, Martin J Somerville, Cynthia Hawkins, Mohamed Abdelhaleem, Vijay Ramsawami, Gino R Somers, Lianna Kyriakopoulou, Johann K Hitzler, Mary Shago, Daniel A Morgenstern, Uri Tabori, Stephen Meyn, Meredith S Irwin, David Malkin, Adam Shlien
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations. Nature cancer (2022)
Anita Villani, Scott Davidson, Nisha Kanwar, Winnie W Lo, Yisu Li, Sarah Cohen-Gogo, Fabio Fuligni, Lisa-Monique Edward, Nicholas Light, Mehdi Layeghifard, Ricardo Harripaul, Larissa Waldman, Bailey Gallinger, Federico Comitani, Ledia Brunga, Reid Hayes, Nathaniel D Anderson, Arun K Ramani, Kyoko E Yuki, Sasha Blay, Brittney Johnstone, Cara Inglese, Rawan Hammad, Catherine Goudie, Andrew Shuen, Jonathan D Wasserman, Rosemarie E Venier, Marianne Eliou, Miranda Lorenti, Carol Ann Ryan, Michael Braga, Meagan Gloven-Brown, Jianan Han, Maria Montero, Famida Spatare, James A Whitlock, Stephen W Scherer, Kathy Chun, Martin J Somerville, Cynthia Hawkins, Mohamed Abdelhaleem, Vijay Ramsawami, Gino R Somers, Lianna Kyriakopoulou, Johann K Hitzler, Mary Shago, Daniel A Morgenstern, Uri Tabori, Stephen Meyn, Meredith S Irwin, David Malkin, Adam Shlien
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations. Nature cancer 4 (2) (2022)
Anita Villani, Scott Davidson, Nisha Kanwar, Winnie W Lo, Yisu Li, Sarah Cohen-Gogo, Fabio Fuligni, Lisa-Monique Edward, Nicholas Light, Mehdi Layeghifard, Ricardo Harripaul, Larissa Waldman, Bailey Gallinger, Federico Comitani, Ledia Brunga, Reid Hayes, Nathaniel D Anderson, Arun K Ramani, Kyoko E Yuki, Sasha Blay, Brittney Johnstone, Cara Inglese, Rawan Hammad, Catherine Goudie, Andrew Shuen, Jonathan D Wasserman, Rosemarie E Venier, Marianne Eliou, Miranda Lorenti, Carol Ann Ryan, Michael Braga, Meagan Gloven-Brown, Jianan Han, Maria Montero, Famida Spatare, James A Whitlock, Stephen W Scherer, Kathy Chun, Martin J Somerville, Cynthia Hawkins, Mohamed Abdelhaleem, Vijay Ramsawami, Gino R Somers, Lianna Kyriakopoulou, Johann K Hitzler, Mary Shago, Daniel A Morgenstern, Uri Tabori, Stephen Meyn, Meredith S Irwin, David Malkin, Adam Shlien
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations. Nature cancer 4 (2) (2022)
Anita Villani, Scott Davidson, Nisha Kanwar, Winnie W Lo, Yisu Li, Sarah Cohen-Gogo, Fabio Fuligni, Lisa-Monique Edward, Nicholas Light, Mehdi Layeghifard, Ricardo Harripaul, Larissa Waldman, Bailey Gallinger, Federico Comitani, Ledia Brunga, Reid Hayes, Nathaniel D Anderson, Arun K Ramani, Kyoko E Yuki, Sasha Blay, Brittney Johnstone, Cara Inglese, Rawan Hammad, Catherine Goudie, Andrew Shuen, Jonathan D Wasserman, Rosemarie E Venier, Marianne Eliou, Miranda Lorenti, Carol Ann Ryan, Michael Braga, Meagan Gloven-Brown, Jianan Han, Maria Montero, Famida Spatare, James A Whitlock, Stephen W Scherer, Kathy Chun, Martin J Somerville, Cynthia Hawkins, Mohamed Abdelhaleem, Vijay Ramsawami, Gino R Somers, Lianna Kyriakopoulou, Johann K Hitzler, Mary Shago, Daniel A Morgenstern, Uri Tabori, Stephen Meyn, Meredith S Irwin, David Malkin, Adam Shlien
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations. Nature cancer 4 (2) (2022)
Anita Villani, Scott Davidson, Nisha Kanwar, Winnie W Lo, Yisu Li, Sarah Cohen-Gogo, Fabio Fuligni, Lisa-Monique Edward, Nicholas Light, Mehdi Layeghifard, Ricardo Harripaul, Larissa Waldman, Bailey Gallinger, Federico Comitani, Ledia Brunga, Reid Hayes, Nathaniel D Anderson, Arun K Ramani, Kyoko E Yuki, Sasha Blay, Brittney Johnstone, Cara Inglese, Rawan Hammad, Catherine Goudie, Andrew Shuen, Jonathan D Wasserman, Rosemarie E Venier, Marianne Eliou, Miranda Lorenti, Carol Ann Ryan, Michael Braga, Meagan Gloven-Brown, Jianan Han, Maria Montero, Famida Spatare, James A Whitlock, Stephen W Scherer, Kathy Chun, Martin J Somerville, Cynthia Hawkins, Mohamed Abdelhaleem, Vijay Ramsawami, Gino R Somers, Lianna Kyriakopoulou, Johann K Hitzler, Mary Shago, Daniel A Morgenstern, Uri Tabori, Stephen Meyn, Meredith S Irwin, David Malkin, Adam Shlien
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations. Nature cancer 4 (2) (2022)

Sasha Blay.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sasha Blay